Intended for healthcare professionals

Miguel O'Ryan

Miguel O’Ryan is Full Professor at the Microbiology and Mycology Program at the Faculty of Medicine, University of Chile where he currently holds the position of Director for International Affairs. He was Vice President for Research and Development of the University of Chile until August 2012, Director for Research and Development of the Faculty of Medicine until July 2014, and previously Director of the Microbiology and Mycology Program. Professor O’Ryan qualified at the Catholic University of Chile and studied paediatric infectious diseases at the University of Texas Health Sciences Center, Houston, Texas. He served as the President of the Chilean Infectious Disease Society from 1998–1999. His research has focused in three main areas: a) molecular and clinical aspects of enteric disease (mainly rotavirus, norovirus and more recently Helicobacter pylori), b) new pediatric vaccines, and c) infection in the immunecompromised host. He was the principle investigator for the multinational trial of the human rotavirus vaccine (NEJM January 2006). Professor O’Ryan's research and expert reviews and editorials have been widely published in 108 indexed articles. He has co-authored 28 book chapters on topics that include enteric viruses, parasitic diseases in children, and medications used in paediatrics. Professor O’Ryan is an active member of the World Society for Pediatric Infectious Diseases (WSPID), Pediatric Infectious Disease Society of America (PIDS), the Sociedad Chilena de Infectologia and the Sociedad Latinoamericana de Infectologia Pediatrica (SLIPE) and currently part of the Executive Committee of ISID. He is currently He has been/is International Editor of the Journal of Pediatrics, the Pediatric Infectious Disease Journal, and the British Medical Journal, and he chaired the III World Congress of Pediatric Infectious Diseases in 2002. Dr. O’Ryan was elected member of the Chilean National Academy of Medicine in 2012.

I have the following interests to declare:

Dean Faculty of Medicine, Universidad de Chile

Research grants:
1. Bharat Biotech International Limited.
2. Janssen Vaccines & Prevention B.V